|
Volumn 27, Issue 4, 2011, Pages
|
World experience after more than a decade of clinical hand transplantation: update from the Louisville hand transplant program.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALEMTUZUMAB;
CANCER ANTIBODY;
IMMUNOSUPPRESSIVE AGENT;
MONOCLONAL ANTIBODY;
ADULT;
ALLOTRANSPLANTATION;
CASE REPORT;
CONVALESCENCE;
GRAFT REJECTION;
HAND;
HAND INJURY;
HUMAN;
MALE;
MIDDLE AGED;
POSTOPERATIVE COMPLICATION;
REVIEW;
SENSATION;
TRANSPLANTATION;
TRAUMATIC AMPUTATION;
TREATMENT OUTCOME;
UNITED STATES;
ADULT;
AMPUTATION, TRAUMATIC;
ANTIBODIES, MONOCLONAL, HUMANIZED;
ANTIBODIES, NEOPLASM;
GRAFT REJECTION;
HAND;
HAND INJURIES;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
KENTUCKY;
MALE;
MIDDLE AGED;
POSTOPERATIVE COMPLICATIONS;
RECOVERY OF FUNCTION;
SENSATION;
TRANSPLANTATION, HOMOLOGOUS;
TREATMENT OUTCOME;
MLCS;
MLOWN;
|
EID: 84857165083
PISSN: None
EISSN: 15581969
Source Type: Journal
DOI: 10.1016/j.hcl.2011.08.004 Document Type: Review |
Times cited : (66)
|
References (0)
|